Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-252
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKuemmel, Andreas-
dc.contributor.authorAlflen, Astrid-
dc.contributor.authorSchmidt, Lars Henning-
dc.contributor.authorSebastian, Martin-
dc.contributor.authorWiewrodt, Rainer-
dc.contributor.authorSchulze, Arik Bernard-
dc.contributor.authorBuhl, Roland-
dc.contributor.authorRadsak, Markus-
dc.date.accessioned2018-12-19T12:30:04Z-
dc.date.available2018-12-19T13:30:04Z-
dc.date.issued2018-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/254-
dc.description.abstractSoluble Triggering Receptor Expressed on Myeloid Cells 1 (sTREM-1) can be found in the sera of patients with infectious, autoimmune and malignant diseases. The primary objective of this study was to investigate the prognostic significance of sTREM-1 in lung cancer patients. We analyzed the sera of 164 patients with lung cancer of all histologies and all stages at the time of diagnosis. We employed an ELISA using the anti-TREM-1 clone 6B1.1G12 mAb and recombinant human TREM-1. Patient data was collected retrospectively by chart review. In ROC-analysis, a sTREM-1 serum level of 163.1  pg/ml showed the highest Youden-Index. At this cut-off value sTREM-1 was a marker of short survival in patients with NSCLC (median survival 8.5 vs. 13.3 months, p = 0.04). A Cox regression model showed stage (p < 0.001) and sTREM-1 (p = 0.011) to indicate short survival. There were no differences in sTREM-1 serum values among patients with or without infection, pleural effusion or COPD. sTREM-1 was not associated with metastasis at the time of diagnosis and was not a predictor of subsequent metastasis. In SCLC patients sTREM-1 levels were lower than in NSCLC patients (p = 0.001) and did not predict survival. sTREM-1 did not correlate with CRP or the number of neutrophils. In non-small cell lung cancer patients, sTREM-1 in serum has prognostic significance.en_GB
dc.description.sponsorshipDFG, Open Access-Publizieren Universität Mainz / Universitätsmedizin-
dc.language.isoeng-
dc.rightsCC BYde_DE
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleSoluble triggering receptor expressed on myeloid cells 1 in lung canceren_GB
dc.typeZeitschriftenaufsatzde_DE
dc.identifier.doihttp://doi.org/10.25358/openscience-252-
jgu.type.dinitypearticle-
jgu.type.versionPublished versionen_GB
jgu.type.resourceText-
jgu.organisation.departmentFB 04 Medizin-
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleScientific reports-
jgu.journal.volume8-
jgu.pages.alternativeArt. 10766-
jgu.publisher.year2018-
jgu.publisher.nameMacmillan Publishers Limited, part of Springer Nature-
jgu.publisher.placeLondon-
jgu.publisher.urihttp://dx.doi.org/10.1038/s41598-018-28971-0-
jgu.publisher.issn2045-2322-
jgu.organisation.placeMainz-
jgu.subject.ddccode610-
opus.date.accessioned2018-12-19T12:30:04Z-
opus.date.modified2019-01-10T10:23:24Z-
opus.date.available2018-12-19T13:30:04-
opus.subject.dfgcode00-000-
opus.organisation.stringFB 04: Medizin: Institut für Immunologiede_DE
opus.organisation.stringFB 04: Medizin: III. Medizinische Klinik und Poliklinikde_DE
opus.identifier.opusid58708-
opus.institute.number0412-
opus.institute.number0427-
opus.metadataonlyfalse-
opus.type.contenttypeKeinede_DE
opus.type.contenttypeNoneen_GB
opus.affiliatedBuhl, Roland-
opus.affiliatedRadsak, Markus-
jgu.publisher.doi10.1038/s41598-018-28971-0
jgu.organisation.rorhttps://ror.org/023b0x485
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
58708.pdf1.52 MBAdobe PDFView/Open